A secret algorithm is transforming DNA evidence. This defendant could be the first to scrutinize it.
By Justin Jouvenal,
Boston Globe
| 07. 13. 2021
The Exxon clerk never got a good look at the assailants who robbed him at gunpoint in Fairfax County, so investigators hoped to bolster their case with the smallest of clues: the minuscule number of skin cells one perpetrator left behind when he grabbed the victim’s shirt.
Crime labs that have long pulled DNA from blood or semen have been pushing the frontiers of forensics by teasing genetic material from ever tinier and more challenging samples, such as sneaker sweat. But this time, the Virginia crime lab could not make a match because of a ubiquitous problem: DNA from too many people was on the shirt.
So authorities turned to advanced software that its creator promises will sort complex DNA mixtures much like a prism breaks down white light. The software doesn’t provide a direct “match” but assesses the probability that a suspect’s DNA is included in the sample. In the Fairfax case, police had a tip about one suspected robber’s name, and the software backed it up.
TrueAllele is reshaping DNA analysis, providing key evidence in thousands of homicides...
Related Articles
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...